Starling Oncology

Starling Oncology, formerly known as The Oncology Institute (TOI), is a leading value-based oncology group in the United States. The company operates over 100 clinics and network locations across five states, providing specialized cancer care to approximately 2.1 million patients. Starling Oncology integrates a technology-enabled care model through its proprietary Starling Nexus platform, which unifies clinical decision support, evidence-based pathways, and prior authorization into a single digital workflow. In addition to direct patient care, the company offers clinical trials, transfusion services, and specialty pharmacy services, aiming to improve NCCN guideline compliance and reduce administrative burdens in oncology.